Clinical Trials Directory

Trials / Completed

CompletedNCT07336576

Treatment Strategy for Adult Congenital Biliary Dilation

Surgery-Oriented Classification and Treatment Strategy for Adult Congenital Biliary Dilation

Status
Completed
Phase
Study type
Observational
Enrollment
234 (actual)
Sponsor
Beijing Tsinghua Chang Gung Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The management of congenital biliary dilations (CBDs), including choledochal cysts, represents one of the most challenging areas in hepatobiliary surgery due to their potential implications for long-term morbidity and malignant transformation. While CBDs have a relatively low incidence in Western populations (1/150,000-1/100,000), the prevalence is notably higher in Asian countries (1/1,000), making it a significant global health concern. Although complete surgical resection remains the standard of care, the optimal extent of resection and reconstruction strategy, particularly for complex disease patterns, continues to be debated. To address these challenges, the current study proposes a novel surgery-oriented classification system for adult CBD based on the analysis of 234 consecutive cases.

Conditions

Interventions

TypeNameDescription
PROCEDUREhepatectomy、liver transplantation、hepaticojejunostomyresection of the diseased bile duct, elimination of secondary lesions, and restoration of biliary-enteric continuity.

Timeline

Start date
2024-10-01
Primary completion
2025-06-01
Completion
2025-07-01
First posted
2026-01-13
Last updated
2026-01-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07336576. Inclusion in this directory is not an endorsement.